OBETICHOLIC ACID | N207999 | INTERCEPT PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Intercept Pharmaceuticals, Inc. v. Zenara Pharma Private Limited 6 patentsANDA 214855obeticholic acid | D. Del. | 2022-09-16 | Terminated 2024-03-06 | — |
Intercept Pharmaceuticals, Inc. et al v. Dr. Reddy's Laboratories, Inc. et al 7 patentsANDA 214899obeticholic acid | D. Del. | 2021-01-13 | Terminated 2022-09-02 | — |
Intercept Pharmaceuticals, Inc. et al v. Optimus Pharma Pvt. Ltd. et al 7 patentsANDA 214935obeticholic acid | D. Del. | 2020-09-11 | Terminated 2023-01-17 | — |
Intercept Pharmaceuticals, Inc. et al v. MSN Laboratories Private Limited et al 5 patentsANDA 215017obeticholic acid | D. Del. | 2020-09-10 | Terminated 2023-02-24 | — |
Intercept Pharmaceuticals, Inc. et al v. Lupin Limited et al 6 patentsANDA 214980obeticholic acid | D. Del. | 2020-08-28 | Terminated 2023-02-21 | — |
Intercept Pharmaceuticals, Inc. et al v. Amneal Pharmaceuticals LLC et al 6 patentsANDA 214810obeticholic acid | D. Del. | 2020-08-28 | Terminated 2023-01-25 | — |
Intercept Pharmaceuticals, Inc. et al v. Apotex Inc. et al 4 patentsANDA 214862obeticholic acid | D. Del. | 2020-08-21 | Terminated 2023-02-24 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Intercept Pharmaceuticals changed its applicant name from "Intercept Pharms Inc" to "Intercept" for the Ocaliva (obeticholic acid) NDA.
Old: INTERCEPT PHARMS INC
New: INTERCEPT
Intercept Pharmaceuticals changed its applicant name from "Intercept Pharms Inc" to "Intercept" for Ocaliva (obeticholic acid) NDA 207999.
Old: INTERCEPT PHARMS INC
New: INTERCEPT